InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Geller Avi. Director active across 1 company, notably Pasithea Therapeutics Corp.. Cumulatively, 1 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €70k. History available since 19 August 2022. The latest transaction was filed on 19 August 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration